Howard University

Running trials

• Enrolling by invitation

  Alzheimer's Plasma Extension

  NCT06416072· Source

• Active, not recruiting

  A Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease

  NCT05531656· Phase 2· Source

• Enrolling by invitation

  Alzheimer's Disease Neuroimaging Initiative 4

  NCT05617014· Source

• Active, not recruiting

  A Study of Etavopivat in Adults and Adolescents With Sickle Cell Disease (HIBISCUS)

  NCT04624659· Phase 3· Source

• Active, not recruiting

  AHEAD 3-45 Study: A Study to Evaluate Efficacy and Safety of Treatment With Lecanemab in Participants With Preclinical Alzheimer's Disease and Elevated Amyloid and Also in Participants With Early Preclinical Alzheimer's Disease and Intermediate Amyloid

  NCT04468659· Phase 3· Source

• Active, not recruiting

  Aspirin in Reducing Events in the Elderly-Extension (ASPREE-XT)

  NCT07224347· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Alzheimer disease2 recruiting
• Frontotemporal dementia1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Life's End Benefits of cannaBidiol and tetrahYdrocannabinol

  NCT05644262· Phase 2· Source

• Completed

  Research Study Investigating How Well NDec Works in People With Sickle Cell Disease

  NCT05405114· Phase 2· Source

• Completed

  Understanding the Long-term Impact of COVID-19 in Adults (RECOVER)

  NCT05172024· Source

• Completed

  Light Treatment Effectiveness (LITE) Study

  NCT03726489· Source

• Completed

  Alzheimer's Disease Neuroimaging Initiative 3

  NCT02854033· Source

Trial sites

• Howard University11 trials

Conditions

Diseases this institution publishes on or runs trials for.

• Long COVID and ME/CFS8 works · 1 trials